VPC
Vestal Point Capital Portfolio holdings
AUM
$2.73B
1-Year Est. Return
128.57%
This Fund
S&P 500
1 Year Est. Return
+128.57%
AUM
$2.2B
AUM Growth
+$305M
(+16%)
Holding
95
Top Buys
| 1 | +$74.6M | |
| 2 | +$61.3M | |
| 3 | +$55.7M | |
| 4 |
DexCom
DXCM
|
+$51.4M |
| 5 |
Repligen
RGEN
|
+$48.6M |
Top Sells
| 1 | +$108M | |
| 2 | +$92.7M | |
| 3 | +$84M | |
| 4 |
uniQure
QURE
|
+$63.1M |
| 5 |
KalVista Pharmaceuticals
KALV
|
+$54.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$14.8B
| $119M | 5.41% |
600,000
+400,000
|
|
||
2
Arcellx
ACLX
$6.69B
| $103M | 4.66% |
1,250,000
-1,500,000
|
|
||
3
Nuvalent
NUVL
$8.04B
| $95.1M | 4.32% |
1,100,000
+25,000
|
|
||
|
ABVX
4
Abivax
ABVX
$9.12B
| $84.9M | 3.85% |
+1,000,000
|
|
||
5
Alcon
ALC
$39.3B
| $82M | 3.72% |
1,100,000
+575,000
|
|
||
|
BCAX
6
Bicara Therapeutics
BCAX
$1.3B
| $80.5M | 3.65% |
5,100,000
+100,000
|
|
||
7
Amicus Therapeutics
FOLD
$4.51B
| $76.8M | 3.49% |
9,750,000
-2,150,000
|
|
||
8
Globus Medical
GMED
$11.7B
| $71.6M | 3.25% |
1,250,000
+750,000
|
|
||
9
Ionis Pharmaceuticals
IONS
$12.5B
| $70.3M | 3.19% |
1,075,000
+575,000
|
|
||
10
Jazz Pharmaceuticals
JAZZ
$11.4B
| $65.9M | 2.99% |
500,000
-700,000
|
|
||
11
Becton Dickinson
BDX
$46.6B
| $60.8M | 2.76% |
325,000
+300,000
|
|
||
12
Scholar Rock
SRRK
$4.57B
| $55.9M | 2.53% |
1,500,000
|
|
||
13
Immatics
IMTX
$1.41B
| $54.1M | 2.45% |
6,350,000
+100,000
|
|
||
|
14
Repligen
RGEN
$6.86B
| $53.5M | 2.43% |
+400,000
|
|
||
15
Dianthus Therapeutics
DNTH
$3.76B
| $46.4M | 2.11% |
1,180,000
-2,020,000
|
|
||
16
BioMarin Pharmaceuticals
BMRN
$11.7B
| $45M | 2.04% |
830,000
+330,000
|
|
||
17
Xenon Pharmaceuticals
XENE
$4.68B
| $44.2M | 2% |
1,100,000
-900,000
|
|
||
|
18
DexCom
DXCM
$26.1B
| $43.7M | 1.98% |
+650,000
|
|
||
19
Cytokinetics
CYTK
$7.85B
| $39.8M | 1.81% |
725,000
-2,250,000
|
|
||
20
Biogen
BIIB
$27.7B
| $38.5M | 1.75% |
+275,000
|
|
||
|
CDTX
21
DELISTED
Cidara Therapeutics
CDTX
| $38.3M | 1.74% |
400,000
-100,000
|
|
||
|
ATXS
22
DELISTED
Astria Therapeutics
ATXS
| $36.1M | 1.64% |
4,956,000
+434,000
|
|
||
23
Dyne Therapeutics
DYN
$3.26B
| $35.1M | 1.59% |
2,775,000
+2,047,500
|
|
||
24
Tyra Biosciences
TYRA
$1.85B
| $33.9M | 1.54% |
2,425,000
-230,000
|
|
||
25
Abbott
ABT
$192B
| $33.5M | 1.52% |
250,000
+75,000
|
|